Ngai-Yin Chan

Introduction Treatment with direct oral anticoagulants (DOACs), including dabigatran, rivaroxaban, apixaban, and edoxaban, is important for stroke prevention in patients with atrial fibrillation (AF).1 A meta-analysis including 18 trials indicated that DOACs were more efficacious and safer than warfarin in real-world practice for stroke prevention in Asian patients with nonvalvular atrial fibrillation (NVAF).2 Another meta-analysis of 6 studies involving 3,542 Asian and 23,481 non-Asian...

Abstract In this paper, the Asia Pacific Heart Rhythm Society (APHRS) sought to provide practice guidance on AF screening based on recent evidence, with specific considerations relevant to the Asia-Pacific region. A key recommendation is opportunistic screening for people aged ≥65 years (all countries), with systematic screening to be considered for people aged ≥75 years or who have additional risk factors (all countries).